Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41007 in Actinic Keratosis
NCT01265602Phase 3Completed
- Sponsor
- Almirall
- Start
- Nov 2010
- Primary completion
- Mar 2012
- Countries
- 1
01
Overview
A Phase 3 trial of LAS41007 in actinic keratosis (AK), sponsored by Almirall. Started Nov 2010; status: completed.
02
Drugs
LAS41007
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01265602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265602.